Farther Finance Advisors’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.1K Sell
2,492
-1,131
-31% -$7.53K ﹤0.01% 3922
2026
Q1
$19.1K Buy
3,623
+1,639
+83% +$9.2K ﹤0.01% 3694
2025
Q4
$13.9K Buy
1,984
+1,628
+457% +$12.7K ﹤0.01% 3693
2025
Q3
$2.75K Sell
356
-9,604
-96% -$75K ﹤0.01% 4014
2025
Q2
$86.8K Buy
9,960
+8,061
+424% +$58.4K ﹤0.01% 1829
2025
Q1
$14.7K Buy
1,899
+1,784
+1,551% +$18K ﹤0.01% 2541
2024
Q4
$1.04K Buy
115
+22
+24% +$212 ﹤0.01% 3238
2024
Q3
$854 Sell
93
-155
-63% -$1.28K ﹤0.01% 3285
2024
Q2
$2.31K Buy
248
+77
+45% +$939 ﹤0.01% 2733
2024
Q1
$2.54K Buy
171
+115
+205% +$2.09K ﹤0.01% 2388
2023
Q4
$1.21K Sell
56
-101
-64% -$1.86K ﹤0.01% 2646
2023
Q3
$2.92K Sell
157
-47
-23% -$1.1K ﹤0.01% 1713
2023
Q2
$5.17K Buy
204
+151
+285% +$3.8K ﹤0.01% 1418
2023
Q1
$1.37K Sell
53
-31
-37% -$830 ﹤0.01% 1762
2022
Q4
$1.99K Buy
+84
New +$2.27K ﹤0.01% 1451

Other funds holding TDOC

Farther Finance Advisors's TDOC Position: Q2 2026 in Review

Farther Finance Advisors reduced its Teladoc Health (TDOC) stake by 31% in Q2 2026, selling an estimated $7.53K and leaving 2,492 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3922.

Farther Finance Advisors first reported a position in TDOC in Q4 2022 and has held it in 15 quarters since. The position peaked at $86.8K in Q2 2025. 347 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Farther Finance Advisors held 2,492 shares of Teladoc Health worth $21.1K as of Q2 2026.
  • Farther Finance Advisors sold 1,131 Teladoc Health shares in Q2 2026, an estimated $7.53K.
  • Teladoc Health made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #3922 holding.
  • Farther Finance Advisors first reported a position in Teladoc Health in Q4 2022 and has held it in 15 quarters since.
  • Farther Finance Advisors's Teladoc Health position peaked at $86.8K in Q2 2025.
  • 347 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.